James B Yu

Summary

Affiliation: Yale University
Country: USA

Publications

  1. pmc Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity
    James B Yu
    Yale University School of Medicine, Department of Therapeutic Radiology, 40 Park St, New Haven, CT 06511, USA
    J Natl Cancer Inst 105:25-32. 2013
  2. doi request reprint Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer
    James B Yu
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA
    Int J Radiat Oncol Biol Phys 83:e101-7. 2012
  3. doi request reprint Validation of the partin nomogram for prostate cancer in a national sample
    James B Yu
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut, USA
    J Urol 183:105-11. 2010
  4. doi request reprint A new formula for prostate cancer lymph node risk
    James B Yu
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06520, USA
    Int J Radiat Oncol Biol Phys 80:69-75. 2011
  5. doi request reprint Postmastectomy radiation therapy for lymph node-negative, locally advanced breast cancer after modified radical mastectomy: analysis of the NCI Surveillance, Epidemiology, and End Results database
    James B Yu
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06520, USA
    Cancer 113:38-47. 2008
  6. pmc Assessing the impact of a cooperative group trial on breast cancer care in the medicare population
    Pamela R Soulos
    Yale School of Medicine, Primary Care Center, New Haven, CT 06520, USA
    J Clin Oncol 30:1601-7. 2012
  7. pmc The adoption of new adjuvant radiation therapy modalities among Medicare beneficiaries with breast cancer: clinical correlates and cost implications
    Kenneth B Roberts
    Cancer Outcomes, Public Policy, and Effectiveness Research COPPER Center, Yale Comprehensive Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA
    Int J Radiat Oncol Biol Phys 85:1186-92. 2013
  8. doi request reprint Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma
    Ayal A Aizer
    Department of Radiation Oncology, Yale School of Medicine, New Haven, CT, USA
    Int J Radiat Oncol Biol Phys 75:1344-9. 2009
  9. ncbi request reprint Treating locally advanced disease: an analysis of very large, hilar lymph node positive non-small cell lung cancer using the National Cancer Data Base
    Amy C Moreno
    Section of Thoracic Surgery, Yale School of Medicine, New Haven, Connecticut
    Ann Thorac Surg 97:1149-55. 2014
  10. pmc Variation in receipt of radiation therapy after breast-conserving surgery: assessing the impact of physicians and geographic regions
    Aaron J Feinstein
    Cancer Outcomes, Public Policy, and Effectiveness Research COPPER Center, Yale Comprehensive Cancer Center, New Haven, CT, USA
    Med Care 51:330-8. 2013

Collaborators

Detail Information

Publications56

  1. pmc Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity
    James B Yu
    Yale University School of Medicine, Department of Therapeutic Radiology, 40 Park St, New Haven, CT 06511, USA
    J Natl Cancer Inst 105:25-32. 2013
    ..We therefore compared patterns of PRT use, cost, and early toxicity among Medicare beneficiaries with prostate cancer with those of intensity-modulated radiotherapy (IMRT)...
  2. doi request reprint Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer
    James B Yu
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA
    Int J Radiat Oncol Biol Phys 83:e101-7. 2012
    ..We performed a retrospective cohort study of Medicare patients treated with IMRT compared with standard RT to assess outcomes in national practice...
  3. doi request reprint Validation of the partin nomogram for prostate cancer in a national sample
    James B Yu
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut, USA
    J Urol 183:105-11. 2010
    ..The nomogram is based on patients undergoing radical prostatectomy at The Johns Hopkins Medical Institutions. We validated the Partin tables in a large, population based sample...
  4. doi request reprint A new formula for prostate cancer lymph node risk
    James B Yu
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06520, USA
    Int J Radiat Oncol Biol Phys 80:69-75. 2011
    ..The Roach formula (RF) has been criticized as overestimating LN risk. A modification of the RF has been attempted by other investigators using simplified adjustment ratios: the Nguyen formula (NF)...
  5. doi request reprint Postmastectomy radiation therapy for lymph node-negative, locally advanced breast cancer after modified radical mastectomy: analysis of the NCI Surveillance, Epidemiology, and End Results database
    James B Yu
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06520, USA
    Cancer 113:38-47. 2008
    ..The role of postmastectomy radiotherapy (PMRT) for lymph node-negative locally advanced breast carcinoma (T3N0M0) after modified radical mastectomy (MRM) with regard to improvement in survival remains an area of controversy...
  6. pmc Assessing the impact of a cooperative group trial on breast cancer care in the medicare population
    Pamela R Soulos
    Yale School of Medicine, Primary Care Center, New Haven, CT 06520, USA
    J Clin Oncol 30:1601-7. 2012
    ..Although treatment guidelines were changed to indicate that some women could forego RT, the impact of the C9343 results on clinical practice is unclear...
  7. pmc The adoption of new adjuvant radiation therapy modalities among Medicare beneficiaries with breast cancer: clinical correlates and cost implications
    Kenneth B Roberts
    Cancer Outcomes, Public Policy, and Effectiveness Research COPPER Center, Yale Comprehensive Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA
    Int J Radiat Oncol Biol Phys 85:1186-92. 2013
    ..New radiation therapy modalities have broadened treatment options for older women with breast cancer, but it is unclear how clinical factors, geographic region, and physician preference affect the choice of radiation therapy modality...
  8. doi request reprint Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma
    Ayal A Aizer
    Department of Radiation Oncology, Yale School of Medicine, New Haven, CT, USA
    Int J Radiat Oncol Biol Phys 75:1344-9. 2009
    ..To determine whether whole pelvic radiotherapy (WPRT) or prostate-only radiotherapy (PORT) yields improved biochemical disease-free survival (BDFS) in patients with advanced or aggressive prostate adenocarcinoma...
  9. ncbi request reprint Treating locally advanced disease: an analysis of very large, hilar lymph node positive non-small cell lung cancer using the National Cancer Data Base
    Amy C Moreno
    Section of Thoracic Surgery, Yale School of Medicine, New Haven, Connecticut
    Ann Thorac Surg 97:1149-55. 2014
    ..This retrospective study compares the effect of treatment modalities on survival of patients with large NSCLC with hilar lymph node involvement (T3>7 cmN1)...
  10. pmc Variation in receipt of radiation therapy after breast-conserving surgery: assessing the impact of physicians and geographic regions
    Aaron J Feinstein
    Cancer Outcomes, Public Policy, and Effectiveness Research COPPER Center, Yale Comprehensive Cancer Center, New Haven, CT, USA
    Med Care 51:330-8. 2013
    ..Little is known about the impact of physicians and regional factors on the use of RT across LE groups...
  11. doi request reprint The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy
    Ayal A Aizer
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA
    Int J Radiat Oncol Biol Phys 79:379-84. 2011
    ..To assess the impact of pretreatment prostate volume on the development of severe acute genitourinary toxicity in patients undergoing intensity-modulated radiation therapy (IMRT) for prostate cancer...
  12. pmc The cost implications of prostate cancer screening in the Medicare population
    Xiaomei Ma
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut Cancer Outcomes, Public Policy and Effectiveness Research Center, Yale University, New Haven, Connecticut
    Cancer 120:96-102. 2014
    ..Recent debate about prostate-specific antigen (PSA)-based testing for prostate cancer screening among older men has rarely considered the cost of screening...
  13. doi request reprint A prognostic index for predicting lymph node metastasis in minor salivary gland cancer
    Shane Lloyd
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520 8040, USA
    Int J Radiat Oncol Biol Phys 76:169-75. 2010
    ..Large studies examining the clinical and pathological factors associated with nodal metastasis in minor salivary gland cancer are lacking in the literature...
  14. doi request reprint Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database
    Amy C Moreno
    Section of Thoracic Surgery, Yale School of Medicine, New Haven, Connecticut 06520, USA
    J Surg Res 184:10-8. 2013
    ..The objective of this study was to evaluate the effect of surgery in the presence and absence of neoadjuvant radiation (NRT) on survival of patients with T3N0 >7-cm NSCLCs...
  15. doi request reprint Survival and intracranial control of patients with 5 or more brain metastases treated with gamma knife stereotactic radiosurgery
    Ann C Raldow
    Departments of Therapeutic Radiology Neurosurgery, Yale School of Medicine, New Haven, CT Hofstra North Shore, LIJ School of Medicine, Great Neck, NY
    Am J Clin Oncol 36:486-90. 2013
    ..Limited data are available to help inform decisions about stereotactic radiosurgery for patients with ≥5 brain metastases. We therefore performed a retrospective analysis of patients treated for >5 brain metastases...
  16. pmc Patterns of use and short-term complications of breast brachytherapy in the national medicare population from 2008-2009
    Carolyn J Presley
    Yale University School of Medicine, New Haven, CT 06520, USA
    J Clin Oncol 30:4302-7. 2012
    ..Brachytherapy has disseminated into clinical practice as an alternative to whole-breast irradiation (WBI) for early-stage breast cancer; however, current national treatment patterns and associated complications remain unknown...
  17. pmc The prognostic importance of midline involvement in oral tongue cancer
    Shane Lloyd
    Division of Otolaryngology, Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06510, USA
    Am J Clin Oncol 35:468-73. 2012
    ..To examine the importance of midline involvement and other clinicopathologic factors in predicting the rate of contralateral lymph node metastasis and survival in oral tongue squamous cell carcinoma...
  18. ncbi request reprint The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population
    Danil V Makarov
    Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, United States
    J Urol 187:97-102. 2012
    ..According to guidelines most men with incident prostate cancer do not require staging imaging. We determined the population level prevalence and correlates of appropriate and inappropriate imaging in this cohort...
  19. doi request reprint Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy
    Henry S Park
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA
    Int J Radiat Oncol Biol Phys 83:1365-73. 2012
    ..To evaluate the influence of immortal time bias on observational cohort studies of postoperative radiotherapy (PORT) and the effectiveness of sequential landmark analysis to account for this bias...
  20. pmc For-profit hospital ownership status and use of brachytherapy after breast-conserving surgery
    Sounok Sen
    Cancer Outcomes, Public Policy and Effectiveness Research COPPER Center, Yale Cancer Center and Yale University School of Medicine, New Haven, CT
    Surgery 155:776-88. 2014
    ..Among Medicare beneficiaries, we examined whether hospital ownership status is associated with the use of breast brachytherapy-a newer and more expensive modality-as well as overall RT...
  21. doi request reprint Surveillance, Epidemiology, and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin
    James B Yu
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA
    Am J Clin Oncol 33:125-7. 2010
    ..Microcystic adnexal carcinoma (MAC) is a very rare cancer of the skin. It has only been described previously in case reports and small retrospective series...
  22. doi request reprint Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy
    Shane Lloyd
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06520 8040, USA
    Am J Clin Oncol 34:76-81. 2011
    ..The effect of adjuvant radiation therapy (RT) on survival in patients with adenoid cystic carcinoma (ACC) is much debated. Studies with large numbers of patients and long follow-up are lacking in the literature...
  23. pmc The influence of regional health system characteristics on the surgical management and receipt of post operative radiation therapy for glioblastoma multiforme
    Sanjay Aneja
    Yale School of Medicine, New Haven, CT, USA
    J Neurooncol 112:393-401. 2013
    ..Policies aimed at narrowing disparities in treatment may need to focus on addressing regional variations in oncology resources...
  24. pmc Age, race, sex, stage, and incidence of cutaneous lymphoma
    Lynn D Wilson
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06510, USA
    Clin Lymphoma Myeloma Leuk 12:291-6. 2012
    ..These findings have significant implications regarding need for earlier diagnosis and understanding the reasons for racial disparity in age and stage of presentation...
  25. doi request reprint Testicular doses in image-guided radiotherapy of prostate cancer
    Jun Deng
    Department of Therapeutic Radiology, Yale University, New Haven, CT 06510 3221, USA
    Int J Radiat Oncol Biol Phys 82:e39-47. 2012
    ..To investigate testicular doses contributed by kilovoltage cone-beam computed tomography (kVCBCT) during image-guided radiotherapy (IGRT) of prostate cancer...
  26. doi request reprint The association between diffusion of the surgical robot and radical prostatectomy rates
    Danil V Makarov
    Robert Wood Johnson Foundation Clinical Scholars Program, Yale University School of Medicine, New Haven, CT, USA
    Med Care 49:333-9. 2011
    ..Despite its expense and controversy surrounding its benefit, the surgical robot has been widely adopted for the treatment of prostate cancer...
  27. doi request reprint Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer
    James B Yu
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut, USA
    J Thorac Oncol 5:215-9. 2010
    ..This study was performed to evaluate the clinical outcomes of surgery for stage I small cell lung cancer (SCLC)...
  28. ncbi request reprint A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer
    Kimberly L Johung
    Authors Affiliations Departments of Therapeutic Radiology, Medical Oncology, Neurosurgery, Yale University School of Medicine and Yale Center for Analytic Sciences, Yale University School of Public Health, New Haven, Connecticut
    Clin Cancer Res 19:5523-32. 2013
    ..We examined clinical outcomes after gamma knife radiotherapy for NSCLC intracranial metastases to evaluate the use of this model for determining radiosensitive tumor genotypes...
  29. pmc Examining the cost-effectiveness of radiation therapy among older women with favorable-risk breast cancer
    Sounok Sen
    Affiliations of authors Cancer Outcomes, Public Policy and Effectiveness Research COPPER Center, Yale Cancer Center SS, S YW, PRS, JBL, kbr, JBY, SBE, ABC, CPG, Department of Epidemiology and Public Health S YW, Section of General Internal Medicine, Department of Internal Medicine PRS, JBL, CPG, Department of Therapeutic Radiology KBR, JBY, SBE, and Department of Surgery ABC, Yale University School of Medicine, New Haven, CT Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD KDF
    J Natl Cancer Inst 106:dju008. 2014
    ....
  30. doi request reprint Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma
    Ayal A Aizer
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06510, USA
    Radiother Oncol 93:185-91. 2009
    ....
  31. doi request reprint Geographic analysis of the radiation oncology workforce
    Sanjay Aneja
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA
    Int J Radiat Oncol Biol Phys 82:1723-9. 2012
    ..To evaluate trends in the geographic distribution of the radiation oncology (RO) workforce...
  32. doi request reprint Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma/mycosis fungoides: a pilot study
    James B Yu
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520 8040, USA
    Am J Clin Oncol 32:142-4. 2009
    ..This prospective study was initiated to evaluate perceptions of total skin electron beam therapy (TSEBT) by patients with mycosis fungoides who had failed at least 3 prior therapies...
  33. doi request reprint A significant decrease in rectal volume and diameter during prostate IMRT
    Nicole S Anderson
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA
    Radiother Oncol 98:187-91. 2011
    ..To record changes in rectal volume (RV) and diameter (RD) of patients with prostate adenocarcinoma prior to and at an interim period during radiotherapy, which could potentially affect treatment toxicity and tumor control...
  34. ncbi request reprint Determinants of enrollment in cancer clinical trials: the relationship between the current state of knowledge, societal disease burden, and randomized clinical trial enrollment
    Shane Lloyd
    From the aDepartment of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut bMemorial Sloan Kettering Cancer Center, New York, New York cDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut and dUnited States Department of Veterans Affairs, New York University School of Medicine, Departments of Urology, Population Health and Cancer, New York, New York
    J Natl Compr Canc Netw 11:928-36. 2013
    ..01) had the strongest association with planned RCT enrollment. Findings showed, therefore, that planned cancer RCT enrollment is associated with higher societal disease burden, not the quality of a cancer's clinical guidelines. ..
  35. pmc Historical trends in the use of radiation therapy for pediatric cancers: 1973-2008
    Vikram Jairam
    Yale School of Medicine, Department of Therapeutic Radiology, New Haven, Connecticut, USA
    Int J Radiat Oncol Biol Phys 85:e151-5. 2013
    ..This study was undertaken to assess historical trends in the use of radiation therapy (RT) for pediatric cancers over the past 4 decades...
  36. ncbi request reprint Hypofractionated radiation therapy for prostate cancer: risks and potential benefits in a fiscally conservative health care system
    Sanjay Aneja
    Yale School of Medicine, New Haven, Connecticut, USA
    Oncology (Williston Park) 26:512-8. 2012
    ....
  37. doi request reprint A retrospective review of 1349 cases of sebaceous carcinoma
    Tina Dasgupta
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Cancer 115:158-65. 2009
    ..The objective of the current study was to analyze demographic characteristics and outcomes for patients with this malignancy from a large United States-based population registry...
  38. ncbi request reprint Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy
    Ann Raldow
    Therapeutic Radiology, Yale University School of Medicine New Haven, Connecticut 06520 8040, USA
    Oncology (Williston Park) 24:692-700, 702. 2010
    ..We discuss the known side effects from SRT, weigh the cost and benefit of SRT, and discuss possible tools that may improve the cost/benefit ratio for SRT by helping to select patients whom SRT may be more likely to benefit...
  39. doi request reprint Analysis of primary CD30+ cutaneous lymphoproliferative disease and survival from the Surveillance, Epidemiology, and End Results database
    James B Yu
    Department of Therapeutic Radiology, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06520, USA
    J Clin Oncol 26:1483-8. 2008
    ..The primary intention of the analysis of the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) database was to report epidemiologic information and overall survival of patients with PCLPD...
  40. doi request reprint Radiosurgical dose selection for brain metastasis
    James B Yu
    Yale University School of Medicine, Department of Therapeutic Radiology, Smilow Cancer Hospital, New Haven, CT, USA
    Prog Neurol Surg 25:139-47. 2012
    ..Physician knowledge and careful judgment, together with careful treatment planning and delivery can minimize the risks associated with brain metastasis radiosurgery...
  41. doi request reprint The role of postoperative radiation therapy (PORT) in the treatment of extrahepatic bile duct cancer: a surveillance, epidemiology, and end results (SEER) population-based investigation
    James B Yu
    Department of Therapeutic Radiology, Yale School of Medicine, HRT 133, 333 Cedar St, New Haven, CT 06520, USA
    J Gastrointest Cancer 39:11-21. 2008
    ..Extrahepatic bile duct cancers (EBDC) are aggressive cancers for which the importance of the use of postoperative radiation therapy (PORT) in potentially curative cases remains the subject of clinical investigation...
  42. doi request reprint Adjuvant radiotherapy after radical prostatectomy: evidence and analysis
    Ann Raldow
    Yale School of Medicine, New Haven, CT, United States
    Cancer Treat Rev 37:89-96. 2011
    ..Finally, we discuss the cost-effectiveness of ART, in the context of other medical interventions...
  43. ncbi request reprint Delayed cerebral vasculopathy following cranial radiation therapy for pediatric tumors
    Chenyang Wang
    Yale School of Medicine, New Haven, Connecticut
    Pediatr Neurol 50:549-56. 2014
    ....
  44. ncbi request reprint The global cancer divide: relationships between national healthcare resources and cancer outcomes in high-income vs. middle- and low-income countries
    Ali Batouli
    Yale School of Medicine, New Haven, CT, USA
    J Epidemiol Glob Health 4:115-24. 2014
    ..Despite this, little is known about whether cancer outcomes are related to a country's income level, and what aspects of national healthcare systems are associated with improved cancer outcomes...
  45. doi request reprint Role of neurosurgery and radiation therapy in the management of brain tumors
    Toral R Patel
    Department of Neurosurgery, Yale University School of Medicine, New Haven, CT 06520, USA
    Hematol Oncol Clin North Am 26:757-77. 2012
    ..This article reviews the current role of neurosurgery and radiation therapy in the management of primary brain tumors...
  46. ncbi request reprint Geographical information systems: applications and limitations in oncology research
    Sanjay Aneja
    Yale School of Medicine, New Haven, Connecticut, USA
    Oncology (Williston Park) 25:1221-5. 2011
    ..Our aims are to help clinicians and policy makers interpret studies generated using GIS, and to help clinical investigators implement GIS in future research...
  47. ncbi request reprint Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists
    Simon P Kim
    Departments of Urology Internal Medicine, Cancer Outcomes, Public Policy and Effectiveness Research COPPER Center Yale University, New Haven, CT Department of Radiation Oncology, Harvard Medical School, Brigham and Women s Hospital, Boston, MA Department of Surgery, Fox Chase Cancer Center Temple University Health System, Philadelphia, PA Division of Health Care Policy and Research, Knowledge and Evaluation Research Unit Department of Urology, Mayo Clinic, Rochester Division of Health Care Policy and Research, Mayo Clinic, Rochester, MN Department of Radiation Oncology, Cancer Outcomes, Public Policy, and Effectiveness Research Center COPPER, Yale University, New Haven, CT Division of Urology, Harvard Medical School, Brigham and Women s Hospital, Boston, MA HealthPartners Institute for Education and Research, Minneapolis, MN Cancer Prognostics and Health Outcomes, University of Montreal Health Center, Montreal, QC, Canada Bioethics Research Unit, Knowledge and Evaluation Research Unit, Division of General Medicine, Mayo Clinic, Rochester, MN
    Med Care 52:579-85. 2014
    ..With the growing concerns about overtreatment in prostate cancer, the extent to which radiation oncologists and urologists perceive active surveillance (AS) as effective and recommend it to patients are unknown...
  48. ncbi request reprint Significance of histology in determining management of lesions regrowing after radiosurgery
    Sameer K Nath
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA
    J Neurooncol 117:303-10. 2014
    ..In summary, our findings underscore the importance of surgically obtaining tissue in a method that facilitates complete lesional interpretive histology in order to accurately guide ongoing patient management. ..
  49. doi request reprint Comparative effectiveness research in radiation oncology: stereotactic radiosurgery, hypofractionation, and brachytherapy
    Sanjay Aneja
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT Cancer Outcomes, Public Policy, and Effectiveness Research COPPER Center, Yale School of Medicine, New Haven, CT
    Semin Radiat Oncol 24:35-42. 2014
    ..Given the broad scope of radiation oncology, this article focuses on the 3 most common sites requiring radiation treatment: breast, prostate, and lung cancer. ..
  50. doi request reprint Complications of brain tumors and their treatment
    Jill Lacy
    Section of Medical Oncology, Department of Medicine, Yale University School of Medicine, New Haven, CT 06510, USA
    Hematol Oncol Clin North Am 26:779-96. 2012
    ..Recognition of the acute, early delayed, and late complications of brain irradiation is essential to optimize management and mitigate their clinical impact...
  51. ncbi request reprint How radiation oncologists would disclose errors: results of a survey of radiation oncologists and trainees
    Suzanne B Evans
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06510 8040, USA
    Int J Radiat Oncol Biol Phys 84:e131-7. 2012
    ..To analyze error disclosure attitudes of radiation oncologists and to correlate error disclosure beliefs with survey-assessed disclosure behavior...
  52. doi request reprint Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: an update
    Henry S Park
    Yale University School of Medicine, New Haven, CT, USA
    Expert Rev Anticancer Ther 11:1731-8. 2011
    ..We also discuss recent nonrandomized evidence for the use of SRS alone for oligometastatic disease...
  53. doi request reprint Long-term response to fractionated radiotherapy of presumed optic nerve sheath meningioma
    Robert L Lesser
    40 Temple Street Suite 5 B, New Haven, CT 06510, USA
    Br J Ophthalmol 94:559-63. 2010
    ..No major side effects from radiation were seen. CONCLUSIONS Vision, MRI and complication outcomes are favourable for using fractionated conformal radiotherapy for ONSM...
  54. ncbi request reprint Treatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapy
    James B Yu
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520 8040, USA
    Int J Radiat Oncol Biol Phys 70:1542-5. 2008
    ..Primary cutaneous CD30+ anaplastic large-cell lymphoma (CALCL) is a relatively rare and indolent variant of cutaneous T-cell lymphoma (CTCL). This report examines the response of localized disease to radiation alone...
  55. ncbi request reprint A dosimetric evaluation of conventional helmet field irradiation versus two-field intensity-modulated radiotherapy technique
    James B Yu
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520 8040, USA
    Int J Radiat Oncol Biol Phys 68:621-31. 2007
    ..To compare dosimetric differences between conventional two-beam helmet field irradiation (external beam radiotherapy, EBRT) of the brain and a two-field intensity-modulated radiotherapy (IMRT) technique...
  56. doi request reprint Impact of immediate postoperative death on the estimation of a survival benefit from postoperative radiation therapy for cancer of the gallbladder
    James B Yu
    J Clin Oncol 26:4523; author reply 4524-6. 2008